A new clinical trial funded by Breakthrough T1D recently launched and is testing islet cell transplantation paired with Eledon Pharmaceuticals’ investigational immunosuppression therapy tegoprubart in ...

A new clinical trial is investigating tegoprubart with islet cell transplants in people with type 1 diabetes and kidney disease.

Read all the updates from day 2 of Breakthrough T1D's Clinical and Research Congress focused entirely on type 1 diabetes.

Breakthrough T1D’s first-ever Clinical and Research Congress (CRC), focused entirely on type 1 diabetes (T1D), has come to a ...

Hello from Philadelphia, PA! We could not be more thrilled that, after years and years, we have finally kicked off our inaugural Breakthrough T1D Clinical & Research Congress (CRC). This ...

It’s a rainy day in Philadelphia, but the mood at CRC 2026 could not be sunnier! The attendees were positively buzzing (seriously) with how timely and impactful this meeting is. It’s the right time ...

PHILADELPHIA, Pa., Oct. 12, 2026 – Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, announces the conclusion of the inaugural Breakthrough ...

National Diabetes Awareness Month is the perfect time to see what’s next in type 1 diabetes (T1D) research. On Sunday, November 15, Breakthrough T1D invites you to a free research update at the ...

The Breakthrough T1D Youth Ambassador Program (YA) was designed to cultivate youth leaders within the type 1 diabetes (T1D) community. Youth Ambassadors inspire others by sharing their T1D stories, ...